3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Parathyroid Neoplasms
2
Thyroid Neoplasms
1
Thyroid Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Hyperparathyroidism, Primary
1
Hypercalcemia
1
Humoral Hypercalcemia Of Malignancy
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Endocrine Gland Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
lenvatinib
1
Denosumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Cancer Metastatic
×
Denosumab
×
Head & Neck
×
Clear all
NCT03732495
2022-03-29
LENVOS
Centre Leon Berard
Phase 2
Unknown
35 enrolled